El Salvador vs Mali: The number of people with susceptibility test result for rifampicin
El Salvador
26.6
in 2021
Mali
26.76
in 2021
El Salvador rank
135th
Mali rank
134th
The number of people with susceptibility test result for rifampicin over time
- El Salvador
- Mali
How they compare
Mali currently reports 26.76 against 26.6 in El Salvador, a difference of 0.16.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was El Salvador ahead.
El Salvador ranks 135th and Mali ranks 134th of 146 countries.
Across the 2 decades both report, El Salvador averaged higher in 1 and Mali in 1.
Head to head by decade
| Decade | El Salvador | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 34.13 | 3.3 | 30.83 | El Salvador |
| 2020s | 33.06 | 40.18 | 7.12 | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, El Salvador or Mali?
- Mali, at 26.76 against 26.6 in El Salvador as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between El Salvador and Mali?
- 0.16, with Mali ahead.
- How many years of comparable data are there for El Salvador and Mali?
- 5 years are reported by both, from 2017 to 2021.
- How do El Salvador and Mali rank globally for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 135th and Mali ranks 134th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.